Stock Events

Stock Events

C4 Therapeutics (CCCC) Q3 2026 Earnings

11AugConfirmed

Q3 2025

Q4 2025

Q2 2026

Q3 2026

-0.44

-0.35

-0.27

-0.18

Details

Expected EPS

-0.2264

Actual EPS

-0.18

Surprise EPS

0.05

Surprise Percent

+20.49%

Description

C4 Therapeutics (CCCC) has reported earnings of -0.18 per share for Q3 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.